AYTU BIOPHARMA, INC (AYTU) Operating cash flow 2016–2025
AYTU BIOPHARMA, INC (AYTU) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$1.9MFY2025 · since FY2016: -$10.7M → -$1.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$1.9M | -39.6% |
| FY2024 | -$1.4M | +72.9% |
| FY2023 | -$5.1M | +82.2% |
| FY2022 | -$28.8M | -11.0% |
| FY2021 | -$26.0M | +8.5% |
| FY2020 | -$28.4M | -105.1% |
| FY2019 | -$13.8M | +13.2% |
| FY2018 | -$15.9M | -15.3% |
| FY2017 | -$13.8M | -29.8% |
| FY2016 | -$10.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice